Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Epstein-Barr Virus and Thyroid Cancer

Volumen 24, Edición 4, 2019, pp. 369-377
DOI: 10.1615/CritRevOncog.2019031618
Get accessGet access

SINOPSIS

Epstein-Barr virus (EBV) seroprevalence is extremely high worldwide. This member of the herpesvirus family is considered to be a human carcinogen, implicated in lymphoid and epithelial malignancies. Because of its characteristics, EBV has been investigated in thyroid specimens, especially in autoimmune and neoplastic lesions. However, the role of EBV in thyroid diseases is still unclear. Reports on its presence in thyroid cancer (TC) vary drastically according to population and applied methodology. This review presents the history of EBV and TC, aiming to better understand the role of this oncogenic virus in thyroid tumorigenesis. We hope to assist researchers, and we discuss possible approaches to better understand the role of EBV in TC.

REFERENCIAS
  1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1(7335):702-3.

  2. El-Sharkawy A, Al Zaidan L, Malki A. Epstein-Barr virus-associated malignancies: roles of viral oncoproteins in carcinogenesis. Frontiers Oncol. 2018;8:265.

  3. World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. In: Painting, firefighting, and shiftwork, vol. 98. Lyon, France: Interna-tional Agency for Research on Cancer; 2010. p. 492.

  4. Cancer [database on the Internet]. Geneva, Switzerland: World Health Organization. c2018 [cited 2019 Nov 1]. Available from: http://www.who.int/news-room/fact-sheets/detail/cancer.

  5. Delecluse HJ, Feederle R, O'Sullivan B, Taniere P. Epstein-Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol. 2007;60(12):1358-64.

  6. Tsai MH, Lin X, Shumilov A, Bernhardt K, Feederle R, Poirey R, Kopp-Schneider A, Pereira B, Almeida R, Delecluse HJ. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Oncotarget. 2017;8(6): 10238-54.

  7. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-68.

  8. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235(2):323-33.

  9. Epstein A. Burkitt lymphoma and the discovery of Epstein-Barr virus. Br J Haematol. 2012;156(6):777-9.

  10. World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. In: Biological agents. A review of human carcinogens, vol. 100B. Lyon, France: International Agency for Research on Cancer; 2012. p. 441.

  11. Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP. Systematic review of trends in the incidence rates of thyroid cancer. Thyroid. 2016;26(11):1541-52.

  12. Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metabol Clin North Am. 2019;48(1):23-35.

  13. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.

  14. Marcello MA, Malandrino P, Almeida JF, Martins MB, Cunha LL, Bufalo NE, Pellegriti G, Ward LS. The influence of the environment on the development of thyroid tumors: a new appraisal. Endocrine Rel Cancer. 2014;21(5):T235-54.

  15. Reuters KB, Mamone M, Ikejiri ES, Camacho CP, Nakabashi CCD, Janovsky C, Yang JH, Andreoni DM, Padovani R, Maciel RMB, Vanderlei FAB. Bethesda classification and cytohistological correlation of thyroid nodules in a Brazilian thyroid disease center. Eur Thyroid J. 2018;7(3):133-8.

  16. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646-53.

  17. Brown RL, de Souza JA, Cohen EE. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011;2:193-9.

  18. Carling T, Udelsman R. Thyroid cancer. Ann Rev Med. 2014;65:125-37.

  19. Cheung WY, Chan AC, Loke SL, Srivastava G, Pittaluga S, Lim LY, Ho FC. Latent sites of Epstein-Barr virus infection. Am J Clin Pathol. 1993;100(5):502-6.

  20. Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Itoh T, Tokunaga M, Eizuru Y, Aikou T. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol. 2001;64(4):513-8.

  21. Ludvikova M, Ryska A, Korabecna M, Rydlova M, Michal M. Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis. Histopathology. 2001;39(1):17-24.

  22. Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A, Yanoma S. Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. Human Pathol. 2003;34(11):1170-7.

  23. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2005;75(2):276-81.

  24. Stamatiou D, Derdas SP, Symvoulakis EK, Sakorafas GH, Zoras O, Spandidos DA. Investigation of BK virus, Epstein-Barr virus and human papillomavirus sequences in postoperative thyroid gland specimens. Int J Bio Markers. 2015;30(1):e104-10.

  25. Almeida JFM, Campos AH, Marcello MA, Bufalo NE, Rossi CL, Amaral LHP, Marques AB, Cunha LL, Alvarenga CA, Tincani PC, Tincani AJ, Ward LS. Investigation on the association between thyroid tumorigeneses and herpesviruses. J Endocrinol Invest. 2017;40(8):823-9.

  26. Bychkov A, Keelawat S. Epstein-Barr virus and thyroid cancer: the controversy remains. J Endocrinol Invest. 2017;40(8):891-2.

  27. Homayouni M, Mohammad Arabzadeh SA, Nili F, Razi F, Amoli MM. Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma. Pathol Res Pract. 2017;213(7):854-6.

  28. Moghoofei M, Mostafaei S, Nesaei A, Etemadi A, Sadri Nahand J, Mirzaei H, Rashidi B, Babaei F, Khodabandehlou N. Epstein-Barr virus and thyroid cancer: the role of viral expressed proteins. J Cell Physiol. 2019;234(4):3790-9.

  29. Yu ST, Ge JN, Li RC, Wei ZG, Sun BH, Jiang YM, Luo JY, Liu H, Lei ST. Is Epstein-Barr virus infection associated with thyroid tumorigenesis? A southern China cohort study. Frontiers Oncol. 2019;9:312.

  30. Tomita Y, Ohsawa M, Kanno H, Matsuzuka F, Kuma K, Aozasa K. Sporadic activation of Epstein-Barr virus in thyroid lymphoma. Leuk Lymph. 1995;19(1-2):129-34.

  31. Takahashi K, Kashima K, Daa T, Yokoyama S, Nakayama I, Noguchi S. Contribution of Epstein-Barr virus to development of malignant lymphoma of the thyroid. Pathol Int. 1995;45(5):366-74.

  32. Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol. 1999;112(2):263-70.

  33. Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin's lymphoma. Am J Clin Pathol. 2002;117(2):259-67.

  34. Sathiyamoorthy K, Chen J, Longnecker R, Jardetzky TS. The complexity in herpesvirus entry. Curr Opin Virol. 2017;24:97-104.

  35. Sathiyamoorthy K, Jiang J, Mohl BS, Chen J, Zhou ZH, Longnecker R, Jardetzky TS. Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies. Proc Natl Acad Sci. 2017;114(41):E8703-10.

  36. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol. 2011;9(5):369-81.

  37. Baquero E, Albertini AA, Gaudin Y. Recent mechanistic and structural insights on class III viral fusion glycoproteins. Curr Op Struct Biol. 2015;33:52-60.

  38. Chesnokova LS, Ahuja MK, Hutt-Fletcher LM. Epstein-Barr virus glycoprotein gB and gHgL can mediate fusion and entry in trans, and heat can act as a partial surrogate for gHgL and trigger a conformational change in gB. J Virol. 2014;88(21):12193-201.

  39. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 2003;9(3):307-14.

  40. Kanda T. EBV-Encoded latent genes. Adv Exper Med Biol. 2018;1045:377-94.

  41. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001;1(1):75-82.

  42. Ribeiro J, Oliveira C, Malta M, Sousa H. Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review. Future Oncol. 2017;13(6):567-79.

  43. Jha HC, Banerjee S, Robertson ES. The role of Y-herpesviruses in cancer pathogenesis. Pathogens. 2016; 5(1):E18.

  44. Xing L, Kieff E. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J Virol. 2007;81(18):9967-75.

  45. Kaneda A, Matsusaka K, Aburatani H, Fukayama M. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res. 2012;72(14):3445-50.

  46. Frappier L. EBNA1. Curr Topics Microbiol Immunol. 2015;391:3-34.

  47. Wang Q, Lingel A, Geiser V, Kwapnoski Z, Zhang L. Tumor suppressor p53 stimulates the expression of Epstein-Barr virus latent membrane protein 1. J Virol. 2017;91(20):e00312-17.

  48. Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S. Co-expression of p53 and BCL-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Cancer Lett. 2000;160(2):199-208.

  49. Kaul R, Murakami M, Choudhuri T, Robertson ES. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol. 2007;81(19): 10352-61.

  50. Kang MS, Kieff E. Epstein-Barr virus latent genes. Exper Mol Med. 2015;47:e131.

  51. Kondo S, Wakisaka N, Schell MJ, Horikawa T, Sheen TS, Sato H, Furukawa M, Pagano JS, Yoshizaki T. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an ETS binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer. 2005;115(3):368-76.

  52. Chew MM, Gan SY, Khoo AS, Tan EL. Interleukins, laminin and Epstein-Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 2010;10:574.

  53. Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, Su IJ, Chang Y. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. J Virol. 2012;86(12):6656-67.

  54. Elgui de Oliveira D, Muller-Coan BG, Pagano JS. Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers. Trends Microbiol. 2016;24(8):649-64.

  55. Satoh T, Wada R, Yajima N, Imaizumi T, Yagihashi S. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly. J Clin Exp Hematopathol. 2014;54(1):75-84.

  56. Wu R, Sattarzadeh A, Rutgers B, Diepstra A, van den Berg A, Visser L. The microenvironment of classical Hodgkin's lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor. Blood Cancer J. 2018;8(1):e622.

  57. Alibek K, Baiken Y, Kakpenova A, Mussabekova A, Zhussupbekova S, Akan M, Sultankulov B. Implication of human herpesviruses in oncogenesis through immune evasion and supression. Infect Agents Cancer. 2014; 9(1):3.

  58. Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, Rosato A. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica. 2010;95(10):1769-77.

  59. Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ. Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products. Sem Cancer Biol. 2008;18(6):397-408.

  60. Cunha LL, Marcello MA, Ward LS. The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocrine Rel Cancer. 2014;21(3):R85-103.

  61. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu I, Ablashi DV, Gallo RC, Menezes J. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol. 1992;149(1):181-7.

  62. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2): 125-39.

  63. Dossus L, Franceschi S, Biessy C, Navionis AS, Travis RC, Weiderpass E, Scalbert A, Romieu I, Tjenneland A, Olsen A, Overvad K, Boutron-Ruault MC, Bonnet F, Fournier A, Fortner RT, Kaaks R, Aleksandrova K, Trichopoulou A, La Vecchia C, Peppa E, Tumino R, Panico S, Palli D, Agnoli C, Vineis P, Bueno-de-Mesquita HBA, Peeters PH, Skeie G, Zamora-Ros R, Chirlaque MD, Ardanaz E, Sanchez MJ, Ramon Quiros J, Dorronsoro M, Sandstrom M, Nilsson LM, Schmidt JA, Khaw KT, Tsilidis KK, Aune D, Riboli E, Rinaldi S. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer. 2018;142(7):1332-42.

  64. Marcello MA, Cunha LL, Batista FA, Ward LS. Obesity and thyroid cancer. Endocrine Rel Cancer. 2014;21(5):T255-71.

  65. Marcello MA, Sampaio AC, Geloneze B, Vasques AC, Assumpcao LV, Ward LS. Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer. 2012;64(8):1190-5.

  66. Bentz GL, Liu R, Hahn AM, Shackelford J, Pagano JS. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-p. Virology. 2010;402(1):121-8.

  67. Morrison TE, Mauser A, Wong A, Ting JP, Kenney SC. Inhibition of IFN-y signaling by an Epstein-Barr virus immediate-early protein. Immunity. 2001;15(5):787-99.

  68. Michaud F, Coulombe F, Gaudreault E, Paquet-Bouchard C, Rola-Pleszczynski M, Gosselin J. Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes. PLoS One. 2010;5(7):e11908.

  69. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-a-induced apoptosis in Burkitt's lymphoma. EMBO J. 2002;21(5):954-65.

  70. Shah KM, Stewart SE, Wei W, Woodman CB, O'Neil JD, Dawson CW, Young LS. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene. 2009;28(44):3903-14.

  71. Pang MF, Lin KW, Peh SC. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Biol Lett. 2009;14(2):222-47.

  72. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol. 2008;82(7):3654-64.

  73. Mohr CF, Kalmer M, Gross C, Mann MC, Sterz KR, Kieser A, Fleckenstein B, Kress AK. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-KB in lymphocytes and contributes to their invasive migration. Cell Commun Signal. 2014; 12:46.

  74. Ho CH, Chen CL, Li WY, Chen CJ. Decoy receptor 3, up-regulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Carcinogenesis. 2009;30(8):1443-51.

  75. Shen Z, Zeng Y, Guo J, Wu Y, Jiang X, Ding R, Wu C, Li R, Luo B, Zeng C, Jiang H, Jie W. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression. J Trans Med. 2013;11:217.

  76. Cunha LL, Soares FA, Vassallo J, Ward LS. The role of tumor-infiltrating lymphocytes in papillary thyroid carcinomas. J Endocrinol Invest. 2011;34(9):733.

  77. Souza SL, Montalli Da Assumpcao LV, Ward LS. Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer. Thyroid. 2003;13(5):491-5.

  78. de Almeida JFM, Ward LS. Thyroid autoimmune diseases and thyroid tumors: would EBV infection be the link? J Cell Physiol. 2019:234(11):19141-2.

  79. Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Ludian J, Kiszczak-Bochynska E, Smolen A, Rolinski J, Pyzik D. Does the Epstein-Barr virus play a role in the pathogenesis of Graves' disease? Int J Mol Sci. 2019;20(13):E3145.

  80. Nagata K, Fukata S, Kanai K, Satoh Y, Segawa T, Kuwamoto S, Sugihara H, Kato M, Murakami I, Hayashi K, Sairenji T. The influence of Epstein-Barr virus reactivation in patients with Graves' disease. Viral Immunol. 2011;24(2):143-9.

  81. Thomas D, Karachaliou F, Kallergi K, Vlachopapadopoulou E, Antonaki G, Chatzimarkou F, Fotinou A, Kaldrymides P, Michalacos S. Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine. 2008;33(2):171-5.

  82. Takano T. Natural history of thyroid cancer (review). Endocrine J. 2017;64(3):237-44.

  83. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418-28.

  84. Schlumberger MJ, Torlantano M. Papillary and follicular thyroid carcinoma. Best Pract Res Clin Endocrinol Metabol. 2000;14(4):601-13.

CITADO POR
  1. Soliman Shimaa Hassan AbdelAziz, Orlacchio Arturo, Verginelli Fabio, Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis, Microorganisms, 9, 6, 2021. Crossref

  2. Cao Ya, Xie Longlong, Shi Feng, Tang Min, Li Yueshuo, Hu Jianmin, Zhao Lin, Zhao Luqing, Yu Xinfang, Luo Xiangjian, Liao Weihua, Bode Ann M., Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study, Signal Transduction and Targeted Therapy, 6, 1, 2021. Crossref

  3. Albehair Maan A, Alagga Abdulrahman A, Ghulam Weaam Z, Alomair Abdullatif M, AlFaraj Dunya, Thyroid Storm: Unusual Presentation and Complication, Cureus, 2021. Crossref

  4. Surman Magdalena, Kędracka-Krok Sylwia, Wilczak Magdalena, Rybczyński Piotr, Jankowska Urszula, Przybyło Małgorzata, Comparative Proteomic Profiling of Ectosomes Derived from Thyroid Carcinoma and Normal Thyroid Cells Uncovers Multiple Proteins with Functional Implications in Cancer, Cells, 11, 7, 2022. Crossref

  5. Shechter Oren, Sausen Daniel G., Gallo Elisa S., Dahari Harel, Borenstein Ronen, Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments, International Journal of Molecular Sciences, 23, 22, 2022. Crossref

62291 Vistas de artículos 39 Descargas de artículos Métrica
62291 PUNTOS DE VISTA 39 DESCARGAS 5 Crossref CITAS Google
Scholar
CITAS

Artículos con contenido similar:

Role of Epstein-Barr Virus in Glioblastoma Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 4
Elizabeth Ortega-Soto, Icela Palma-Lara, Victor Manuel Luna-Pineda, Guadalupe Garcia-Chacón, Cristina Trejo-Solis, Marcela Salazar-Garcia, Juan Xicohtencatl-Cortes, Sara A. Ochoa, Sergio Zavala-Vega, Daniel Rembao-Bojorquez, Eugenio Vázquez-Meraz, Simón Guzmán-Bucio, Elva Jiménez-Hernández, José Arellano-Galindo, Juan Manuel Mejía-Aranguré, Israel Torres-Ramirez de Arellano, Concepción Sánchez-Gómez, Ariadna Cruz-Córdova, Luis Eduardo Ucharima-Corona
MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 2
Faezeh Ghasemi, Atefeh Amiri, Hamed Mirzaei, Aria Masoudifar, Reza Salarinia, Arad Mobasher Aghdam
Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 2
Rama Rao Malla, Seema Kumari
Risk Factors for Esophageal Cancer, with an Emphasis on the Role of Specificity Protein Transcription Factors in Prognosis and Therapy Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 4
Ananya Kurri, Sohail Siraj, Riyaz Basha, Krishna Patel, Nuri Hamby
Cancer Stem Cells in the Mechanism of Metal Carcinogenesis Journal of Environmental Pathology, Toxicology and Oncology, Vol.31, 2012, issue 3
Zhuo Zhang, Gang Chen, Jia Luo, Lei Wang, Fei Chen, Xianglin Shi
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain